Loading…

Advances in Chitosan-Based Nanoparticles for Drug Delivery

Nanoparticles (NPs) have an outstanding position in pharmaceutical, biological, and medical disciplines. Polymeric NPs based on chitosan (CS) can act as excellent drug carriers because of some intrinsic beneficial properties including biocompatibility, biodegradability, non-toxicity, bioactivity, ea...

Full description

Saved in:
Bibliographic Details
Published in:International journal of molecular sciences 2021-09, Vol.22 (17), p.9652
Main Authors: Mikušová, Veronika, Mikuš, Peter
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c478t-bb9e46186bcf3af45a58172425ec7330a4d31cee717db49ee99f7d69d61714803
cites cdi_FETCH-LOGICAL-c478t-bb9e46186bcf3af45a58172425ec7330a4d31cee717db49ee99f7d69d61714803
container_end_page
container_issue 17
container_start_page 9652
container_title International journal of molecular sciences
container_volume 22
creator Mikušová, Veronika
Mikuš, Peter
description Nanoparticles (NPs) have an outstanding position in pharmaceutical, biological, and medical disciplines. Polymeric NPs based on chitosan (CS) can act as excellent drug carriers because of some intrinsic beneficial properties including biocompatibility, biodegradability, non-toxicity, bioactivity, easy preparation, and targeting specificity. Drug transport and release from CS-based particulate systems depend on the extent of cross-linking, morphology, size, and density of the particulate system, as well as physicochemical properties of the drug. All these aspects have to be considered when developing new CS-based NPs as potential drug delivery systems. This comprehensive review is summarizing and discussing recent advances in CS-based NPs being developed and examined for drug delivery. From this point of view, an enhancement of CS properties by its modification is presented. An enhancement in drug delivery by CS NPs is discussed in detail focusing on (i) a brief summarization of basic characteristics of CS NPs, (ii) a categorization of preparation procedures used for CS NPs involving also recent improvements in production schemes of conventional as well as novel CS NPs, (iii) a categorization and evaluation of CS-based-nanocomposites involving their production schemes with organic polymers and inorganic material, and (iv) very recent implementations of CS NPs and nanocomposites in drug delivery.
doi_str_mv 10.3390/ijms22179652
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_7d683ad7375f4859913aec143cabf6d8</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_7d683ad7375f4859913aec143cabf6d8</doaj_id><sourcerecordid>2571238178</sourcerecordid><originalsourceid>FETCH-LOGICAL-c478t-bb9e46186bcf3af45a58172425ec7330a4d31cee717db49ee99f7d69d61714803</originalsourceid><addsrcrecordid>eNpVkd1PwjAUxRujEUTffDZLfHXaz3X1wQTBDxKiL_rcdG0HW8aK7UbCf-8QJPDUm95zf_fcHACuEbwnRMCHolwEjBEXCcMnoI8oxjGECT89qHvgIoQSQkwwE-egRyiDmCWwDx6HZqVqbUNU1NFoXjQuqDp-VsGa6EPVbql8U-iq6-fOR2PfzqKxrYqV9etLcJarKtir3TsA368vX6P3ePr5NhkNp7GmPG3iLBOWJihNMp0TlVOmWIo4pphZzQmBihqCtLUccZNRYa0QOTeJMAniiKaQDMBkyzVOlXLpi4Xya-lUIf8-nJ_JnUnZzaVEGU44y2nKhEBEWY0o0SrLE5N2rKcta9lmC2u0rRuvqiPocacu5nLmVjKlBHW2O8DtDuDdT2tDI0vX-rq7X2LGESadaLPmbqvS3oXgbb7fgKDcpCYPU-vkN4eu9uL_mMgvBfSSXg</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2571238178</pqid></control><display><type>article</type><title>Advances in Chitosan-Based Nanoparticles for Drug Delivery</title><source>PubMed Central</source><source>ProQuest Publicly Available Content database</source><creator>Mikušová, Veronika ; Mikuš, Peter</creator><creatorcontrib>Mikušová, Veronika ; Mikuš, Peter</creatorcontrib><description>Nanoparticles (NPs) have an outstanding position in pharmaceutical, biological, and medical disciplines. Polymeric NPs based on chitosan (CS) can act as excellent drug carriers because of some intrinsic beneficial properties including biocompatibility, biodegradability, non-toxicity, bioactivity, easy preparation, and targeting specificity. Drug transport and release from CS-based particulate systems depend on the extent of cross-linking, morphology, size, and density of the particulate system, as well as physicochemical properties of the drug. All these aspects have to be considered when developing new CS-based NPs as potential drug delivery systems. This comprehensive review is summarizing and discussing recent advances in CS-based NPs being developed and examined for drug delivery. From this point of view, an enhancement of CS properties by its modification is presented. An enhancement in drug delivery by CS NPs is discussed in detail focusing on (i) a brief summarization of basic characteristics of CS NPs, (ii) a categorization of preparation procedures used for CS NPs involving also recent improvements in production schemes of conventional as well as novel CS NPs, (iii) a categorization and evaluation of CS-based-nanocomposites involving their production schemes with organic polymers and inorganic material, and (iv) very recent implementations of CS NPs and nanocomposites in drug delivery.</description><identifier>ISSN: 1422-0067</identifier><identifier>ISSN: 1661-6596</identifier><identifier>EISSN: 1422-0067</identifier><identifier>DOI: 10.3390/ijms22179652</identifier><identifier>PMID: 34502560</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Animals ; Biocompatibility ; Biodegradability ; Biological activity ; Chitosan ; Chitosan - chemistry ; Classification ; controlled release ; Crosslinking ; Drug carriers ; Drug Carriers - chemistry ; Drug delivery ; Drug delivery systems ; Drug Delivery Systems - methods ; Drug Liberation ; Drugs ; Humans ; Hydrophobic and Hydrophilic Interactions ; Molecular Structure ; Nanocomposites ; Nanoparticles ; Nanoparticles - chemistry ; new formulations ; Pharmaceutical industry ; Pharmaceutical Preparations - administration &amp; dosage ; Pharmaceutical Preparations - chemistry ; Physicochemical properties ; Polymers ; Proteins ; Review ; targeting ; Toxicity</subject><ispartof>International journal of molecular sciences, 2021-09, Vol.22 (17), p.9652</ispartof><rights>2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2021 by the authors. 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c478t-bb9e46186bcf3af45a58172425ec7330a4d31cee717db49ee99f7d69d61714803</citedby><cites>FETCH-LOGICAL-c478t-bb9e46186bcf3af45a58172425ec7330a4d31cee717db49ee99f7d69d61714803</cites><orcidid>0000-0001-5755-9970</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2571238178/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2571238178?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,44590,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34502560$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mikušová, Veronika</creatorcontrib><creatorcontrib>Mikuš, Peter</creatorcontrib><title>Advances in Chitosan-Based Nanoparticles for Drug Delivery</title><title>International journal of molecular sciences</title><addtitle>Int J Mol Sci</addtitle><description>Nanoparticles (NPs) have an outstanding position in pharmaceutical, biological, and medical disciplines. Polymeric NPs based on chitosan (CS) can act as excellent drug carriers because of some intrinsic beneficial properties including biocompatibility, biodegradability, non-toxicity, bioactivity, easy preparation, and targeting specificity. Drug transport and release from CS-based particulate systems depend on the extent of cross-linking, morphology, size, and density of the particulate system, as well as physicochemical properties of the drug. All these aspects have to be considered when developing new CS-based NPs as potential drug delivery systems. This comprehensive review is summarizing and discussing recent advances in CS-based NPs being developed and examined for drug delivery. From this point of view, an enhancement of CS properties by its modification is presented. An enhancement in drug delivery by CS NPs is discussed in detail focusing on (i) a brief summarization of basic characteristics of CS NPs, (ii) a categorization of preparation procedures used for CS NPs involving also recent improvements in production schemes of conventional as well as novel CS NPs, (iii) a categorization and evaluation of CS-based-nanocomposites involving their production schemes with organic polymers and inorganic material, and (iv) very recent implementations of CS NPs and nanocomposites in drug delivery.</description><subject>Animals</subject><subject>Biocompatibility</subject><subject>Biodegradability</subject><subject>Biological activity</subject><subject>Chitosan</subject><subject>Chitosan - chemistry</subject><subject>Classification</subject><subject>controlled release</subject><subject>Crosslinking</subject><subject>Drug carriers</subject><subject>Drug Carriers - chemistry</subject><subject>Drug delivery</subject><subject>Drug delivery systems</subject><subject>Drug Delivery Systems - methods</subject><subject>Drug Liberation</subject><subject>Drugs</subject><subject>Humans</subject><subject>Hydrophobic and Hydrophilic Interactions</subject><subject>Molecular Structure</subject><subject>Nanocomposites</subject><subject>Nanoparticles</subject><subject>Nanoparticles - chemistry</subject><subject>new formulations</subject><subject>Pharmaceutical industry</subject><subject>Pharmaceutical Preparations - administration &amp; dosage</subject><subject>Pharmaceutical Preparations - chemistry</subject><subject>Physicochemical properties</subject><subject>Polymers</subject><subject>Proteins</subject><subject>Review</subject><subject>targeting</subject><subject>Toxicity</subject><issn>1422-0067</issn><issn>1661-6596</issn><issn>1422-0067</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNpVkd1PwjAUxRujEUTffDZLfHXaz3X1wQTBDxKiL_rcdG0HW8aK7UbCf-8QJPDUm95zf_fcHACuEbwnRMCHolwEjBEXCcMnoI8oxjGECT89qHvgIoQSQkwwE-egRyiDmCWwDx6HZqVqbUNU1NFoXjQuqDp-VsGa6EPVbql8U-iq6-fOR2PfzqKxrYqV9etLcJarKtir3TsA368vX6P3ePr5NhkNp7GmPG3iLBOWJihNMp0TlVOmWIo4pphZzQmBihqCtLUccZNRYa0QOTeJMAniiKaQDMBkyzVOlXLpi4Xya-lUIf8-nJ_JnUnZzaVEGU44y2nKhEBEWY0o0SrLE5N2rKcta9lmC2u0rRuvqiPocacu5nLmVjKlBHW2O8DtDuDdT2tDI0vX-rq7X2LGESadaLPmbqvS3oXgbb7fgKDcpCYPU-vkN4eu9uL_mMgvBfSSXg</recordid><startdate>20210906</startdate><enddate>20210906</enddate><creator>Mikušová, Veronika</creator><creator>Mikuš, Peter</creator><general>MDPI AG</general><general>MDPI</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0001-5755-9970</orcidid></search><sort><creationdate>20210906</creationdate><title>Advances in Chitosan-Based Nanoparticles for Drug Delivery</title><author>Mikušová, Veronika ; Mikuš, Peter</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c478t-bb9e46186bcf3af45a58172425ec7330a4d31cee717db49ee99f7d69d61714803</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Animals</topic><topic>Biocompatibility</topic><topic>Biodegradability</topic><topic>Biological activity</topic><topic>Chitosan</topic><topic>Chitosan - chemistry</topic><topic>Classification</topic><topic>controlled release</topic><topic>Crosslinking</topic><topic>Drug carriers</topic><topic>Drug Carriers - chemistry</topic><topic>Drug delivery</topic><topic>Drug delivery systems</topic><topic>Drug Delivery Systems - methods</topic><topic>Drug Liberation</topic><topic>Drugs</topic><topic>Humans</topic><topic>Hydrophobic and Hydrophilic Interactions</topic><topic>Molecular Structure</topic><topic>Nanocomposites</topic><topic>Nanoparticles</topic><topic>Nanoparticles - chemistry</topic><topic>new formulations</topic><topic>Pharmaceutical industry</topic><topic>Pharmaceutical Preparations - administration &amp; dosage</topic><topic>Pharmaceutical Preparations - chemistry</topic><topic>Physicochemical properties</topic><topic>Polymers</topic><topic>Proteins</topic><topic>Review</topic><topic>targeting</topic><topic>Toxicity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mikušová, Veronika</creatorcontrib><creatorcontrib>Mikuš, Peter</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection (Proquest)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest Research Library</collection><collection>Research Library (Corporate)</collection><collection>ProQuest Publicly Available Content database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>International journal of molecular sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mikušová, Veronika</au><au>Mikuš, Peter</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Advances in Chitosan-Based Nanoparticles for Drug Delivery</atitle><jtitle>International journal of molecular sciences</jtitle><addtitle>Int J Mol Sci</addtitle><date>2021-09-06</date><risdate>2021</risdate><volume>22</volume><issue>17</issue><spage>9652</spage><pages>9652-</pages><issn>1422-0067</issn><issn>1661-6596</issn><eissn>1422-0067</eissn><abstract>Nanoparticles (NPs) have an outstanding position in pharmaceutical, biological, and medical disciplines. Polymeric NPs based on chitosan (CS) can act as excellent drug carriers because of some intrinsic beneficial properties including biocompatibility, biodegradability, non-toxicity, bioactivity, easy preparation, and targeting specificity. Drug transport and release from CS-based particulate systems depend on the extent of cross-linking, morphology, size, and density of the particulate system, as well as physicochemical properties of the drug. All these aspects have to be considered when developing new CS-based NPs as potential drug delivery systems. This comprehensive review is summarizing and discussing recent advances in CS-based NPs being developed and examined for drug delivery. From this point of view, an enhancement of CS properties by its modification is presented. An enhancement in drug delivery by CS NPs is discussed in detail focusing on (i) a brief summarization of basic characteristics of CS NPs, (ii) a categorization of preparation procedures used for CS NPs involving also recent improvements in production schemes of conventional as well as novel CS NPs, (iii) a categorization and evaluation of CS-based-nanocomposites involving their production schemes with organic polymers and inorganic material, and (iv) very recent implementations of CS NPs and nanocomposites in drug delivery.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>34502560</pmid><doi>10.3390/ijms22179652</doi><orcidid>https://orcid.org/0000-0001-5755-9970</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1422-0067
ispartof International journal of molecular sciences, 2021-09, Vol.22 (17), p.9652
issn 1422-0067
1661-6596
1422-0067
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_7d683ad7375f4859913aec143cabf6d8
source PubMed Central; ProQuest Publicly Available Content database
subjects Animals
Biocompatibility
Biodegradability
Biological activity
Chitosan
Chitosan - chemistry
Classification
controlled release
Crosslinking
Drug carriers
Drug Carriers - chemistry
Drug delivery
Drug delivery systems
Drug Delivery Systems - methods
Drug Liberation
Drugs
Humans
Hydrophobic and Hydrophilic Interactions
Molecular Structure
Nanocomposites
Nanoparticles
Nanoparticles - chemistry
new formulations
Pharmaceutical industry
Pharmaceutical Preparations - administration & dosage
Pharmaceutical Preparations - chemistry
Physicochemical properties
Polymers
Proteins
Review
targeting
Toxicity
title Advances in Chitosan-Based Nanoparticles for Drug Delivery
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T17%3A49%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Advances%20in%20Chitosan-Based%20Nanoparticles%20for%20Drug%20Delivery&rft.jtitle=International%20journal%20of%20molecular%20sciences&rft.au=Miku%C5%A1ov%C3%A1,%20Veronika&rft.date=2021-09-06&rft.volume=22&rft.issue=17&rft.spage=9652&rft.pages=9652-&rft.issn=1422-0067&rft.eissn=1422-0067&rft_id=info:doi/10.3390/ijms22179652&rft_dat=%3Cproquest_doaj_%3E2571238178%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c478t-bb9e46186bcf3af45a58172425ec7330a4d31cee717db49ee99f7d69d61714803%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2571238178&rft_id=info:pmid/34502560&rfr_iscdi=true